Subcutaneous Daratumumab in Patients (PTS) With Relapsed or Refractory Multiple Myeloma (RRMM): An Open-Label, Multicenter, Dose Escalation Phase 1B Study (PAVO)

M. Mateos V, A. Chari, H. Nah, H. Lokhorst, J. L. Kaufman, P. Moreau, A. Oriol, T. Plesner, L. Benboubker, P. Hellemans, T. Masterson, P. L. Clemens, K. Liu, J. San-Miguel, S. Z. Usmani

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskningpeer review

OriginalsprogEngelsk
TidsskriftHaematologica
Vol/bind103
Udgave nummerSuppl. 1
Sider (fra-til)32-33
Antal sider2
ISSN0390-6078
StatusUdgivet - 18. apr. 2018
Begivenhed1st European Myeloma Network Meeting, Turin - turino, Italien
Varighed: 19. apr. 201821. apr. 2018

Konference

Konference1st European Myeloma Network Meeting, Turin
LandItalien
Byturino
Periode19/04/201821/04/2018

Bibliografisk note

1st Meeting of the European-Myeloma-Network, Turin, ITALY, APR 19-21, 2018

Citationsformater